Bioventus
Bioventus LLC is a medical technology company specializing in orthobiologic solutions aimed at enhancing bone healing and managing osteoarthritis. The company offers a range of products, including active healing therapies that support the recovery of bone fractures and alleviate chronic pain associated with osteoarthritis. Its portfolio features injection therapies for osteoarthritic joints, surgical orthobiologics, and bone healing solutions that promote the body’s natural healing processes. Key offerings include the EXOGEN Ultrasound Bone Healing System and various joint fluid therapies. Bioventus is recognized for its innovative and effective products, which adhere to high quality standards and evidence-based practices. Headquartered in Durham, North Carolina, Bioventus employs around 500 people and generates approximately $240 million in annual revenue. The company operates a distribution network to make its products available to healthcare providers. Bioventus was established in 2011, evolving from the Biologics Division of Smith & Nephew.
8 past transactions
CartiHeal
Acquisition in 2021
CartiHeal Ltd. is a medical device company based in Kfar Sava, Israel, specializing in the development of innovative solutions for cartilage and bone disorders. Founded in 2009, the company has pioneered a cell-free implant technology known as Agili-C, designed to address focal articular cartilage and osteochondral defects. This off-the-shelf implant promotes the regeneration of true hyaline cartilage and its underlying subchondral bone through a minimally invasive procedure, without the need for cells or growth factors. CartiHeal's Agili-C implant represents a significant advancement in the treatment of cartilage injuries, which can lead to severe pain, disability, and early onset of osteoarthritis if left untreated. By offering a well-tolerated and effective solution, CartiHeal aims to meet a critical need in the field of cartilage repair and regeneration.
Trice Medical
Series D in 2021
Trice Medical, Inc. is a company that specializes in the development of innovative orthopedic diagnostic devices featuring integrated camera-enabled and needle-based technologies. Founded in 2011 and headquartered in Malvern, Pennsylvania, Trice Medical aims to enhance patient care by providing immediate and accurate diagnostic solutions that can be administered in a physician's office. Their products facilitate minimally invasive procedures that are designed to be painless, cosmetically undetectable, and of surgical grade quality. By optimizing the diagnostic process, Trice Medical seeks to eliminate inaccuracies associated with traditional indirect modalities, thereby reducing costs for the healthcare system while improving the overall patient experience.
Misonix
Acquisition in 2021
Misonix is a leading medical device company specializing in ultrasonic surgical technology. The company designs, manufactures, and markets innovative devices that enhance clinical outcomes in various surgical fields, including neurosurgery, orthopedic surgery, plastic surgery, and wound care. Misonix's product portfolio features advanced ultrasonic platforms such as aspirators for soft and hard tissue removal, instruments for laparoscopic procedures, and devices for wound cleansing and debridement. Additionally, its offerings include tools for precision bone cutting and sculpting, as well as liposuction instruments aimed at improving body aesthetics. Notable products include BoneScalpel, NeXus, Sequel, SonaStar, SonicOne, Theragenesis, TheraSkin, and Therion. Misonix serves a global market, with a presence in regions such as the United States and the United Kingdom, contributing to the overall value of the healthcare system.
Vaporox
Corporate Round in 2021
Vaporox, Inc. is a company focused on developing advanced therapeutic delivery systems for treating skin wounds. It specializes in Vaporous Hyperoxia Therapy (VHT), a patented technology that utilizes low-frequency, non-contact ultrasound to atomize a liquid, optionally infused with antimicrobials, allowing for continuous delivery to wound beds. This innovative approach is particularly effective for a range of skin conditions, including diabetic foot ulcers, amputations, burns, frostbite, gangrene, pressure ulcers, and skin grafts. Founded in 2016 and headquartered in Denver, Colorado, Vaporox aims to provide a comfortable and cost-effective treatment alternative in the healthcare sector. The company was previously known as Wound Care, Inc. before rebranding in January 2019.
Bioness
Acquisition in 2021
Bioness Inc. is a medical device company based in Valencia, California, founded in 2004. It specializes in designing, developing, and distributing innovative technologies aimed at helping individuals with neurological impairments regain mobility and independence. Bioness offers a range of non-invasive devices, including the L300 foot drop system and the L300 Plus, which provides electrical stimulation to assist with foot drop and thigh weakness. The H200 serves as a wireless hand rehabilitation system, facilitating hand movements for tasks such as reaching and grasping. Additionally, Bioness produces StimRouter, an implantable neuromodulation device designed to manage chronic intractable pain originating from peripheral nerves. Through its advanced medical devices, Bioness addresses conditions resulting from strokes, multiple sclerosis, traumatic brain injuries, and other central nervous system disorders.
CartiHeal
Corporate Round in 2020
CartiHeal Ltd. is a medical device company based in Kfar Sava, Israel, specializing in the development of innovative solutions for cartilage and bone disorders. Founded in 2009, the company has pioneered a cell-free implant technology known as Agili-C, designed to address focal articular cartilage and osteochondral defects. This off-the-shelf implant promotes the regeneration of true hyaline cartilage and its underlying subchondral bone through a minimally invasive procedure, without the need for cells or growth factors. CartiHeal's Agili-C implant represents a significant advancement in the treatment of cartilage injuries, which can lead to severe pain, disability, and early onset of osteoarthritis if left untreated. By offering a well-tolerated and effective solution, CartiHeal aims to meet a critical need in the field of cartilage repair and regeneration.
CartiHeal
Corporate Round in 2018
CartiHeal Ltd. is a medical device company based in Kfar Sava, Israel, specializing in the development of innovative solutions for cartilage and bone disorders. Founded in 2009, the company has pioneered a cell-free implant technology known as Agili-C, designed to address focal articular cartilage and osteochondral defects. This off-the-shelf implant promotes the regeneration of true hyaline cartilage and its underlying subchondral bone through a minimally invasive procedure, without the need for cells or growth factors. CartiHeal's Agili-C implant represents a significant advancement in the treatment of cartilage injuries, which can lead to severe pain, disability, and early onset of osteoarthritis if left untreated. By offering a well-tolerated and effective solution, CartiHeal aims to meet a critical need in the field of cartilage repair and regeneration.
BioStructures
Acquisition in 2015
BioStructures, LLC is a medical device company founded in 2009 and headquartered in Newport Beach, California. The company specializes in developing bioresorbable bone graft products aimed at enhancing bone regeneration and remodeling for various spinal surgical applications. Its product portfolio includes a range of innovative offerings, such as bioactive bone graft putty, mineralized collagen scaffolds, and demineralized bone matrices, among others. BioStructures is committed to advancing surgical outcomes through its synthetic and allograft implant technologies. As of late 2015, it operates as a subsidiary of Bioventus LLC.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.